{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-009689","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2026-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.656045+00:00","generated_at":"2026-05-15T14:49:40.604543+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Evofem reports FY2025 net sales $20.2M (+4% YoY), income from operations $3.4M vs loss $7.7M","bullets":["Record net sales of $20.2M in FY2025, fifth consecutive year of growth; up 4% from $19.4M in FY2024.","Income from operations of $3.4M in FY2025 vs loss of $7.7M in FY2024; net income of $0.3M vs net loss of $9.0M.","Reduced total operating expenses by 38% to $16.8M, including gains from vendor settlement and royalty liability change.","Q4 2025 net sales of $9.6M (+35% YoY); operating income of $3.3M vs loss of $1.0M; net income of $2.8M vs loss of $3.0M.","Since Oct 2025: targeting 55-60% manufacturing cost reduction for PHEXX and SOLOSEC; UAE pricing certificates received."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-009689","json":"https://secwatch.observer/filing/0001493152-26-009689.json","markdown":"https://secwatch.observer/filing/0001493152-26-009689.md","text":"https://secwatch.observer/filing/0001493152-26-009689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315226009689/0001493152-26-009689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315226009689/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T14:49:40.604543+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}